Technical Analysis for HOLX - Hologic, Inc.

Grade Last Price % Change Price Change
B 76.68 0.03% 0.02
HOLX closed up 0.03 percent on Monday, April 19, 2021, on 69 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Apr 27
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical HOLX trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze Ended Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 0.03%
Bollinger Band Squeeze Range Contraction 0.03%
Stochastic Reached Overbought Strength 0.03%
Older End-of-Day Signals for HOLX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hologic, Inc. Description

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company's Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical MRI breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, and ThinPrep system. The company's GYN Surgical segment offers NovaSure system to treat women with excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; Towerfree Hysteroscopy System for the visualization and inspection of the uterine cavity; Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures; and Adiana system, a procedure for permanent female contraception. Its Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems to perform minimally invasive surgical procedures on a patient's extremities. The company sells its products through direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Clinical Medicine Acid Bone IBD 50 Imaging Breast Cancer Treatment Of Breast Cancer Workstation Medical Imaging X Ray MRI Surgical Products Visualization Transcription Biopsy Mammography Radiography Breast Surgery Cancer Screening Fibroids HPV Trident Brachytherapy Diagnostics Hybridization Sentinel Breast Imaging Contraception Medical Imaging Systems Quest Diagnostics

Is HOLX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 85.0
52 Week Low 42.4
Average Volume 1,807,422
200-Day Moving Average 70.20
50-Day Moving Average 74.84
20-Day Moving Average 74.18
10-Day Moving Average 74.92
Average True Range 1.84
ADX 16.82
+DI 28.34
-DI 17.04
Chandelier Exit (Long, 3 ATRs ) 71.64
Chandelier Exit (Short, 3 ATRs ) 75.21
Upper Bollinger Band 76.96
Lower Bollinger Band 71.39
Percent B (%b) 0.95
BandWidth 7.51
MACD Line 0.65
MACD Signal Line 0.23
MACD Histogram 0.4182
Fundamentals Value
Market Cap 19.86 Billion
Num Shares 259 Million
EPS 4.21
Price-to-Earnings (P/E) Ratio 18.21
Price-to-Sales 5.08
Price-to-Book 6.89
PEG Ratio 0.68
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.97
Resistance 3 (R3) 77.93 77.46 77.76
Resistance 2 (R2) 77.46 77.13 77.48 77.68
Resistance 1 (R1) 77.07 76.93 77.27 77.11 77.61
Pivot Point 76.60 76.60 76.70 76.62 76.60
Support 1 (S1) 76.21 76.27 76.41 76.25 75.75
Support 2 (S2) 75.74 76.07 75.76 75.68
Support 3 (S3) 75.35 75.74 75.61
Support 4 (S4) 75.39